London, 23 May 2008 — Celoxica Ltd, a leading provider of High Performance Computing solutions, is pleased to announce that further to the announcement on 29 April 2008, the Share Subscription of up to 200,000,000 Ordinary Shares at a price of 1 pence per share was oversubscribed.
As a consequence, certain of the Directors have therefore agreed to reduce the number of Subscription Shares for which they were to subscribe, in order to allow external investors to achieve their subscriptions in full. The revised number of shares that are being subscribed for by the Directors is 23,500,000 Subscription Shares in aggregate at the Subscription Price. This represents approximately 11.8 per cent. of the maximum number of Subscription Shares. Under the Share Subscription, Lee Staines has agreed to subscribe for 7,500,000 Subscription Shares, Jean-Marc Bouhelier has agreed to subscribe for 15,000,000 Subscription Shares and Jack Fryer has agreed to subscribe for 1,000,000 Subscription Shares, all at the Subscription Price. On completion of the Share Subscription, Lee Staines will hold 7,710,526 Ordinary Shares, representing approximately 2.7 per cent. of the Enlarged Ordinary Share Capital, Jean-Marc Bouhelier will hold 17,105,263 Ordinary Shares, representing approximately 6.0 per cent. of the Enlarged Ordinary Share Capital and Jack Fryer will hold 1,695,743 Ordinary Shares, representing approximately 0.6 per cent. of the Enlarged Ordinary Share Capital.
In addition, the Company is pleased to announce that all resolutions proposed to the extraordinary general meeting held earlier today were duly passed. Admission and dealings in the Subscription Shares are therefore expected to commence on AIM on 27 May 2008.
Following Admission, the Company will have in issue 284,304,435 Ordinary Shares of 1p each.
Certain terms used in this announcement are defined and have the same meaning as in the Company’s announcement of 29 April 2008.
Celoxica is a leading provider of hardware accelerated low-footprint, ultra low latency market data, order entry and risk trading solutions for the global financial services industry. Headquartered in the UK with offices in Chicago and New York, Celoxica delivers trading solutions to automated trading firms, banks and brokers seeking to optimize the performance of their trading applications across multiple asset classes in all market conditions, whilst reducing their total cost of ownership.
– ends –
For additional information, contact:
Lee Staines, President Celoxica Inc
t: +44 207 313 3180 or +1 212 880 2075
Press enquiries to:
Salli Roskilly Saffron Communications
t: +44 1763 208708